MAL-like protein (MALL)

MAL-like protein (MALL) is a member of the proteolipid/MARVEL domain superfamily, structurally related to the canonical MAL protein but encoded by a separate gene. MALL is a tetraspanning integral membrane protein expressed in myelin-forming cells, T cells, and some epithelial cells[1][4]. It is characterized by lipid-like properties, specifically its partitioning into highly ordered (raft) membrane domains. Proteins in the MARVEL family—including MAL, MALL, and others—are involved in processes such as vesicular trafficking, exosome biogenesis, and the targeted delivery of specific proteins to myelin and specialized membrane sites. Though implicated in cellular structure and trafficking, MALL itself is not a receptor, enzyme, transporter, or direct canonical therapeutic target. Aberrant regulation (notably by DNA methylation) and changes in its expression have been linked to certain cancers, and its loss is seen in a subset of carcinomas. It may serve as a cancer biomarker, particularly because its downregulation is associated with malignancy in epithelial tissues. There is no evidence to date that any drugs interact with MALL, nor is it a therapeutic target for pharmacological intervention[1][4]. Some confusion in the literature arises because the canonical MAL protein (non-MALL, gene symbol MAL) is involved in T cell vesicle trafficking and myelin function, and is sometimes implicated in toxin/receptor biology in specialized settings—but MALL is its closest paralogue and primarily shares structural/biogenetic features[1]. There are no known drugs or targeted therapies or established mechanisms of action specific to MALL.

Other names

MALLBENEmalT cell differentiation protein like